| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8219900 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 7 Pages |
Abstract
The MTD of 90Y delivered in conjunction with capecitabine in the setting of intrahepatic cholangiocarcinoma or metastatic disease confined to the liver exceeds 170Â Gy. This is the highest 90Y dose reported to date and has important implications on combined therapy with the radiosensitizing oral chemotherapeutic capecitabine. Further studies are under way.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ryan MD, Mary F. MD, Robert J. MD, Vanessa L. MS, Michael MD, Ali BA, Sheetal MD, Steven MD, Halla MD, Al B. MD, Riad MD,